Atlas Trials

Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population. Database Analysis of Previous Studies Performed in Spain

Clinical trial NCT00998062 · COMPLETED

Trial details

NCT number
NCT00998062
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
DyslipaemiaAtherosclerosis RiskIncreased hsCRPInflammatory and Oxidative Status in the Spanish Population
Start date
2009-11-01
Primary completion
2011-10-01
Enrollment
30181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.